$USDC The GENIUS Act (Generating Evidence on New Innovations in the United States) was passed to improve Medicare coverage and payment for breakthrough medical technologies. Signed into law in 2025, the act empowers the Centers for Medicare & Medicaid Services (CMS) to grant temporary coverage for innovative medical devices approved by the FDA. This ensures quicker patient access to life-saving treatments while gathering real-world evidence on their effectiveness. The GENIUS Act addresses delays that previously hindered adoption of advanced technologies. By promoting innovation and streamlining regulatory processes, the act supports both healthcare advancement and improved patient outcomes in the U.S. healthcare system.
